Massachusetts Medical International Secures RMB 75 Million Series B Funding from Fosun Tonghao, Highlighting Cross-border Healthcare as an Emerging Investment Hotspot

VCBeat (WeChat: vcbeat) learned at the earliest opportunity that the cross-border healthcare platform Mass General International (Meiyu Health)Recently completed a RMB 75 million Series B financing round, with Fosun Tonghao Capital, under the Fosun Group, as the investor.In October 2015, this cross-border healthcare company had previously received a multi-million-yuan investment from Sunshine Ronghui Capital.

With the upgrading of the health and medical industry in recent years, an increasing number of people are traveling abroad for medical diagnosis and treatment. The immense domestic demand for healthcare, combined with overseas cross-border medical resources, has become a new development trend in the healthcare services sector. It is estimated thatThe Market Size of China's Cross-Border Healthcare Is Set to Surpass $10 Billion。

Massachusetts Medical International, established in 2015, specializes in cross-border healthcare services, providing Chinese patients with one-stop solutions including remote consultations with Harvard-affiliated teaching hospitals, medical treatment in the United States, premium health screenings, and medical professional training.

Massachusetts Healthcare International’s global headquarters is located in Boston, USA. The company has established in-depth collaborations with multiple top-tier medical groups in the United States and Europe, including Tufts Medical Center, Partners HealthCare, and Connected Health. It has also formed second-opinion consultation partnerships with Brigham and Women’s Hospital, Dana-Farber Cancer Institute (affiliated with Harvard University), and Massachusetts General Hospital, and has set up primary care facilities.

Meiyu Health is the China-based subsidiary of Massachusetts Medical International Group. Headquartered in Beijing, it maintains branch offices in Shanghai, Guangzhou, Zhengzhou, Hangzhou, Taiyuan, Changsha, and Guiyang, and has established specialized teams in prefecture-level cities such as Nanchang, Nanjing, and Qingdao.

According to the official website of Mass General International, the company has signed cooperation agreements with the health departments of 10 provinces and established partnerships with more than 100 medical institutions.

Its main business activities are as follows:

· Remote Consultation

Remote Consultation Services are applicable in the following two scenarios: 1. The patient has been preliminarily diagnosed by a domestic attending physician with a serious condition such as cancer, but a definitive diagnosis cannot be established; 2. Multiple hospitals have provided differing diagnoses and treatment plans, and the patient seeks a second medical opinion. In these cases, our team collects the patient’s medical records, translates the relevant documents, and obtains detailed reviews from overseas experts, ensuring smooth communication between the patient and physicians throughout the process.

· Medical Treatment and Premium Health Checkups in the United States

1. If patients in China apply for medical treatment in the United States, departure will be arranged after Harvard medical experts have evaluated and confirmed the necessity of cross-border treatment; 2. Users may apply for comprehensive health check-ups in the United States. The team provides end-to-end assistance for both outbound medical treatment and health examinations, with dedicated service teams available both domestically and internationally.

· Healthcare Professional Training

Facilitate short-term research fellowships and training at top-tier U.S. teaching hospitals and medical schools for Chinese scholars in the medical field. Participants can engage in training programs such as the Quality and Leadership Program at Harvard Medical School, the Surgical Robotics Program at Beth Israel Deaconess Medical Center, and programs at Tufts Medical Center.

It is understood that Massachusetts Medical InternationalDelivers thousands of telemedicine consultations annually, serving hundreds of patients seeking medical care in the United States as well as healthcare professionals undergoing training in the United States.。

The core members of the international team all possess overseas medical backgrounds, with the majority being experts, scholars, professors, and physicians from Harvard University-affiliated hospitals. The founder, Wu Gongxiong, holds a Doctor of Medicine (M.D.) degree,With over 12 years of experience at Harvard Medical School.Prior to founding Mass General International, he worked at the Joslin Diabetes Center in Boston.Since 2016, Wu Gongxiong has served as an Investment Partner at Fosun Tonghao Capital.。

Fosun Tonghao Capital, the investing party, is a high-tech venture capital platform under Fosun Group, focusing on healthcare and deep tech sectors. Its lead investments have included Mass General International, Metta Family, Yaoshibang, LinkedCare, Mingyi Zhudao, and Jiuai Guangchangwu.

Investors’ Perspectives: Liu Qikai, founder of Fosun Tonghao Capital, stated that the rise of the overseas medical services industry is driven by heightened health service awareness resulting from rising consumption levels, while the development of the internet has further accelerated the growth of telemedicine and cross-border healthcare. Both Fosun Tonghao Capital and Ronghui Capital expressed optimism about the future direction of Massachusetts Medical International’s business and affirmed their confidence in its management team.

Within less than two years of its establishment, Massachusetts Healthcare has completed its Series B financing. It is reported that this round of financingTo be used for upgrading internet-based products, online brand marketing, and expanding collaborations with overseas medical resources.。